Development of Nanopharmaceutical Therapy for Combat-Related Proliferative Vitreoretinopathy

Abstract

The objective of this study is to develop an anti-fibrotic therapy using pirfenidone-loaded nanostructures to treat proliferative vitreoretinopathy (PVR), a specific type of intraocular fibrosis, in a rabbit model of penetrating eye injury.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2021
Accession Number
AD1152702

Entities

People

  • Andrew Peitzsch
  • Annette Rodriguez
  • Binapani Mahaling
  • Christina Rettinger
  • Erin Lavik
  • Heuy-ching Wang
  • Patrick Hsun
  • Shuaishuai Liu
  • Zakiya Skeete

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cells
  • Craniocerebral Trauma
  • Department Of Defense
  • Detection
  • Electron Microscopy
  • Eye Diseases
  • Eye Injuries
  • Fibrosis
  • Lung Diseases
  • Machine Learning
  • Maryland
  • Medical Personnel
  • Nanoparticles
  • Nanostructures
  • Particle Size
  • Particles
  • Physical Properties
  • Retinal Diseases
  • Therapy

Fields of Study

  • Medicine

Readers

  • Immunology and Pathology
  • Materials Science.
  • Neurotrauma and Rehabilitation Medicine.

Technology Areas

  • Microelectronics